02158.HK
Yidu Tech Inc.
HKSE · Healthcare · Medical - Healthcare Information Services · CN
HKD 3.97
+6.59%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.5B | 790.5M | 715.0M | 807.1M | 804.7M |
| Cost of Revenue | 989.7M | 502.5M | 475.8M | 467.6M | 530.2M |
| Gross Profit | 533.9M | 288.0M | 239.2M | 339.4M | 274.5M |
| Operating Expenses | |||||
| R&D Expense | 349.5M | 159.1M | 186.5M | 232.9M | 342.5M |
| SG&A Expense | 517.4M | 190.9M | 285.5M | 380.2M | 503.6M |
| General & Admin Expense | 206.7M | — | 146.4M | 171.3M | 232.0M |
| Selling & Marketing Expense | 212.7M | — | 139.2M | 208.9M | 271.6M |
| Other Expenses | (211.0M) | 28.2M | (98.7M) | (53.8M) | 391.0K |
| Total Operating Expenses | 655.9M | 378.3M | 373.3M | 559.4M | 979.6M |
| Cost and Expenses | 1.6B | 880.8M | 849.1M | 1.0B | 1.5B |
| Operating Income (EBIT) | (122.0M) | (90.3M) | (134.1M) | (219.9M) | (617.6M) |
| Non-Operating | |||||
| Interest Income | 234.1M | 1.7M | 158.8M | 143.3M | 78.8M |
| Interest Expense | 1.9M | 1.9M | 2.0M | 3.3M | 2.6M |
| Net Interest Income | 230.2M | (171.7K) | 156.8M | 140.0M | 76.2M |
| Other Non-Op Income/Expense | 68.7M | 171.2M | (776.0K) | (1.3M) | 1.1M |
| Non-Operating Income (excl Interest) | 257.2M | — | (1.2M) | (2.0M) | (3.7M) |
| EBT (Pre-Tax Income) | (53.3M) | 81.0M | (134.9M) | (221.2M) | (628.9M) |
| Income Tax Expense | 5.3M | 5.0M | 298.0K | 49.0K | 3.4M |
| Bottom Line | |||||
| Net Income | (47.1M) | 70.2M | (117.8M) | (194.9M) | (628.0M) |
| Earnings from Cont. Ops | (58.7M) | 76.0M | (135.2M) | (221.2M) | (632.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (47.1M) | 70.2M | (117.8M) | (194.9M) | (628.0M) |
| Per Share | |||||
| Basic EPS | (HK$0.05) | HK$0.07 | (HK$0.11) | (HK$0.19) | (HK$0.63) |
| Diluted EPS | (HK$0.05) | HK$0.06 | (HK$0.11) | (HK$0.19) | (HK$0.63) |
| Revenue Per Share | HK$1.42 | HK$0.75 | HK$0.68 | HK$0.77 | HK$0.81 |
| Shares | |||||
| Basic Shares Outstanding | 1.1B | 1.0B | 1.1B | 1.1B | 995.2M |
| Diluted Shares Outstanding | 1.1B | 1.1B | 1.1B | 1.1B | 995.2M |
| Profitability Metrics | |||||
| EBITDA | (318.7M) | (54.9M) | (89.6M) | (170.8M) | (580.0M) |
| D&A | 60.6M | 35.4M | 43.3M | 47.1M | 46.4M |
| EBIT | (379.3M) | (90.3M) | (132.9M) | (217.9M) | (626.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026